Literature DB >> 17380894

[Abberant methylation of p16, HIC1, N33 and GSTP1 genes in tumor epitelium and tumor-associated stromal cells of prostate cancer].

T V Kekeeva, O P Popova, P V Shegaĭ, B Ia Alekseev, Iu Iu Adnreeva, D V Zaletaev, M V Nemtsova.   

Abstract

The methylation status of four genes significant in prostate carcinogenesis p16, HIC1, N33 and GSTP1, were evaluated using quantitative methylationsensitive polymerase chain reaction. Tumor epithelia, tumor-associated stroma, normal epithelia, foci of PIN and benign prostate hyperplasia, and stroma adjacent to tumor tissues were isolated from whole-mount prostatectomy specimens of patients with localized prostate cancer by using laser capture microdissection. We found high levels of gene methylation in the tumor epithelium and tumor-associated stromal cells and some methylation in both hyperplastic epithelium and stromal cells in normal-appearing tissues located adjacent to tumors. Promoter methylation in the non-neoplastic cells of the prostate tumor microenvironment may play an important role in cancer development and progression. We examined the promoter methylation status of pl6, HIC1, N33 and GSTP1 in prostate biopsy fragments and prostate tissues after radical prostatectomy from patients with adenocarcinoma without laser capture microdissection. Methylation frequencies of all genes in tumor samples were considerably lower than frequencies in microdissected tumour samples (HIC1, 71 versus 89%; p16, 22 versus 78%; GSTP1, 32 versus 100%; N33, 20 versus 33%). The laser capture microdissection is required procedure in methylation studies taking into account multifocality and heterogenity of prostate cancer tissue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17380894

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  8 in total

Review 1.  Promoter hypermethylation in prostate cancer.

Authors:  Jong Y Park
Journal:  Cancer Control       Date:  2010-10       Impact factor: 3.302

2.  A pilot genome-scale profiling of DNA methylation in sporadic pituitary macroadenomas: association with tumor invasion and histopathological subtype.

Authors:  Chao Ling; Matthew Pease; Lingling Shi; Vasu Punj; Mark S Shiroishi; Deborah Commins; Daniel J Weisenberger; Kai Wang; Gabriel Zada
Journal:  PLoS One       Date:  2014-04-29       Impact factor: 3.240

3.  DNA methylation in promoter region as biomarkers in prostate cancer.

Authors:  Mihi Yang; Jong Y Park
Journal:  Methods Mol Biol       Date:  2012

4.  Oxidative stress and DNA methylation in prostate cancer.

Authors:  Krishna Vanaja Donkena; Charles Y F Young; Donald J Tindall
Journal:  Obstet Gynecol Int       Date:  2010-06-29

5.  COX-2 (PTGS2) gene methylation in epithelial, subepithelial lymphocyte and stromal tissue compartments in a spectrum of esophageal squamous neoplasia.

Authors:  Sonja P Dawsey; Mark J Roth; Lisa Adams; Nan Hu; Quan-Hong Wang; Philip R Taylor; Karen Woodson
Journal:  Cancer Detect Prev       Date:  2008-07-16

6.  A systematic analysis on DNA methylation and the expression of both mRNA and microRNA in bladder cancer.

Authors:  Jialou Zhu; Zhimao Jiang; Fei Gao; Xueda Hu; Liang Zhou; Jiahao Chen; Huijuan Luo; Jihua Sun; Song Wu; Yonghua Han; Guangliang Yin; Maoshan Chen; Zujing Han; Xianxin Li; Yi Huang; Weixing Zhang; Fangjian Zhou; Tong Chen; Pingping Fa; Yong Wang; Liang Sun; Huimin Leng; Fenghao Sun; Yuchen Liu; Mingzhi Ye; Huanming Yang; Zhiming Cai; Yaoting Gui; Xiuqing Zhang
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

7.  Genetic alterations and epigenetic alterations of cancer-associated fibroblasts.

Authors:  Heng Du; Guowei Che
Journal:  Oncol Lett       Date:  2016-11-30       Impact factor: 2.967

8.  TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo.

Authors:  Peter Horak; Erwin Tomasich; Petr Vaňhara; Kateřina Kratochvílová; Mariam Anees; Maximilian Marhold; Christof E Lemberger; Marion Gerschpacher; Reinhard Horvat; Maria Sibilia; Dietmar Pils; Michael Krainer
Journal:  Sci Rep       Date:  2014-01-17       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.